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Supramolecular chemistry and microfluidics are both scientific fields in recent decades that 
have seen a convergence in literature interest. Supramolecular chemistry has seen exciting 
biologically friendly applications such as the delivery of therapeutic substances or 
supramolecular catalysis both potentially contributing towards the next generation of medicine. 
Microfluidics has also seen promising applications such as fluid handling, cell biology and 
droplet generation. The incorporation of both the fields was explored throughout this thesis, 
more specifically the conjunction of passive droplet generation and the creation of a 
biologically friendly polypeptide supramolecular network was attempted. We demonstrated in 
this work that a functionalised polyproline, consisting of a functionalised hexamer, was able to 
create in aqueous environment a supramolecular network with different morphology according 
to the condition used. Remarkably we demonstrated that these supramolecular networks are 
reversible and chemo-responsive. Passive droplet generation using fluorinated chemicals 
(water/fluorinated oil interface[AP1]), using two cross junction 3-D printed microfluidic designs 
was also demonstrated. However, the desired incorporation of microdroplet and 
supramolecular formation as the aqueous phase decreased in diameter causing self-assembly 
was examined, but was not achieved due to the instability of microdroplets, however future 
project work can be conducted to mitigate this issue of instability.  
 
  




The overall goal outlined throughout this thesis was to create and characterise a biological 
friendly supramolecular network by utilising microfluidic passive microdroplet generation. More 
specifically PP II (polyproline two) was chosen as the biological friendly building block for the 
network to be created within a microdroplet at the water/oil interface. The chemical nature and 
topography of the supramolecular network was then to be characterised. Reasons as to why 
this research was chosen were because of the exciting biological application such as the 
delivery of therapeutic substances or supramolecular catalysis. Throughout this introduction 
key concepts will be mentioned in detail, in conjunction with other concepts to help 
contextualise this thesis.   
1.1 PP II (Polyproline II) overview and why are we using it? 
The key building block compound that was synthesised to create the desire supramolecular 
network was polyproline. More specifically in the case of this research PP II, which is a 
secondary structure. Polyproline has two stable secondary structures PP I (polyproline one) 
and PP II even in short oligomers (as little as three helices has been demonstrated (1)). The 
difference between the two structures is that PP I has a more compact/denser structure and 
has a Cis (at the amide) configuration structure compared to PP II which consists of trans 
amide configuration, both structures present a helical structure with specific periodicity [PPII 
has a periodicity of (n+3) referenced at figure 1]. There were three main reasons as to why 
PP II was considered; the first being that PP II is the most commonly occurring proline in 
aqueous solution which is helped by its trans confirmation that is also favourable within a polar 
solution (carbonyl group in the trans confirmation will be able to engage intermolecular 
hydrogen bonding, hence why it is favourable). The second and the most important reason 
being that PP II has a favourable helical secondary structure, which can be observed at figure 
1. So structurally it is able to be easily manipulated due to its key property; steric hindrance 
and as a result of this PP II trans helical structure means that if you were to observe PP II 
along the helical axis you would see the faces of PP II are 70 to 120 o apart (2)(3)(4), preventing 
the possibility of intramolecular bonding. The third reason is simply that the PP II is a 
biologically friendly building block to create the supramolecular network, the desired biological 
applications that this research could entail such as the delivery of therapeutic substances or 
supramolecular catalysis. Overall PP II helices are the common structure that is preferred in 
polar aqueous solutions with proline, PP II is a good candidate to structurally manipulate due 












    
Figure 1: A : Polyproline II with (n+3) periodicity, for example ‘AA1’ and ‘AA4’ are equivalent.  
B : Top and side views of the Polyproline II (all trans) and I (all cis) helices. 
1.2 Supramolecular chemistry and desired biological applications 
Supramolecular chemistry is where non-covalent intermolecular interactions of weak and 
reversible forces such as hydrogen bonding, van der Waals forces and metal-ligand 
coordination brings compounds together via self-assembly. Supramolecular chemistry is 
useful for understanding biological processes and creating very large complex materials and 
molecular architecture (5). Jean-Marie Lehn who won the Nobel Prize in Chemistry in 1987 and 
was the pioneer effectively into this field coined the term ‘supramolecular chemistry’ (6) and 
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and of the intermolecular bond’ (7), meaning that neighbouring non-covalent compounds will 
come together as a result of interacting, which strongly reiterates what the supramolecular 
field is about. Supramolecular architecture assembly understanding could lead to the 
understanding of biological processes as it mimics those processes, and if you can observe 
record and understand the supramolecular building process you could possibly understand 
the fundamental important interactions that occur at the mesoscopic scale and could lead to 
huge breakthroughs in biological applications such as next-generation medicine also known 
as personalised medicine. [8]. 
 
To briefly outline exciting near future biological applications of supramolecular chemistry, 
which primarily includes delivery of therapeutic substance such as drugs, genes, sensors and 
supramolecular catalysis (to name a few examples). Delivery of therapeutic substances have 
seen a surge of interest due to the issue of the prematurely releasing within healthy tissues 
causing undesired side effects or not reaching the targeted site. This is due to traditional 
delivery methods not adapting to varying physiological conditions within the body, as well as 
permeability of crossing certain membranes and dealing with the immune response (9). 
Supramolecular networks are potentially able to adapt to these changing conditions giving a 
higher degree of accuracy for the release of the substances. Supramolecular catalysis works 
by bringing parts of coordinate ligands to where the reaction takes place, or by providing extra 
interactions for the speed up in reaction between catalysts and substrates (10). In a sense this 
could be highly effective in speeding up important chemical reactions and present exciting 
possibilities.  
1.3 Polypeptide self-assembling supramolecular network 
Polypeptides are biological polymers in which the monomeric units are amino acids linked 
together via peptide bonds, (the carboxyl group of one amino acid and the amine group of the 
next amino acid) (11). Formation of self-assembling supramolecular polypeptide networks, as 
well as characterisation of these networks by utilising TEM (transition electron microscopy) or 
SEM (scanning electron microscopy) and other analytical techniques has been well 
documented throughout literature. For example, an α-helical peptide sequence self-
assembling into ‘objects including nanofibers, nanotubes, and nanosheets’ (12) or coiled 
peptide bundles self-assembling into cage structure (13), potentially being able to be used 
within drug delivery, are two recent literature examples. However, one notable example of an 
article (14) published in 2019 that was more closely related with the goals of this thesis, used 
varying polyproline lengths known as a ‘oligoprolines’. It was demonstrated to self-assembled 
with quaterthiophene (C16H10S4) which is a tetramer sulphur-rich aromatic heterocycles. The 
researchers were able to conclude that although oligoprolines were not able to form a 
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supramolecular network on their own, they were able with another molecular building block. 
The network organisation/shape was also able to change depending on the oligoproline length 
(monolayer, double layer sheets and helical twist structure). This article was able to provide 
support of the theory that a polyproline design was able to self-assemble with an appropriate 
building block, which gave credence to the theorised methodology of this thesis. This thesis 
sets out to accomplish and fill in gaps of knowledge regarding assembly of a polyproline design 
via generated microdroplets and to characterise this network, which will be discussed more in 
depth later within this thesis.   
1.4 Microfluidics overview and droplet generation 
Microfluidics has been given the nickname ‘lab on a chip’, it is the study of manipulating and 
analysing fluids through tens to hundreds microlitre scale channels. Microfluidics has offered 
many advantages over the course of its conception; the first being what was previously 
mentioned in the context of observable interactions at the micrometre and mesomere scale of 
fluids, containing the reagents and solvents to interact differently, providing a more in-depth 
look and better understanding into these interactions (15). The actual practical advantageous 
uses of this technique have been documented as; streamlining complex protocols (maintaining 
conditions), severely reducing cost and amount of solvent used which is not only great 
financially but also environmentally, being able to accurately control the volume occupied by 
samples and reagents in which chemical reactions occur, and also provides (as previously 
mentioned) scalability, but also can analysis batch samples with different solvents with a quick 
result turnover rate (16). With all these advantages microfluidics has been a revelation within 
important cutting-edge fields, particularly within analytical chemistry and biochemistry 
disciplines (17).   
 
There are three main methodologies for microfluidics manipulation; ‘Open microfluidics’, 
‘Continuous-flow microfluidics’ and ‘Droplet microfluidics’, this section of the introduction will 
focus on droplet microfluidics as that is the method that will be referenced and used in the 
methodology sections of this thesis. ‘Droplet microfluidics’ manipulates surface tension 
creating droplets. Typically the water (containing the sample) and the oil are pumped from two 
separate microfluidic channels that eventually join to a single point to create the microdroplets, 
below at figure 2 is a complete overview of the commonly use designs and techniques taken 
from (18) to help illustrate how microdroplets are created, this offers several advantages over 
other microfluidic designs and methods; ‘each droplet is analogous to the traditional chemist’s 
flask’ (18) which essentially means that each droplet is Compartmentalised meaning they can 
have different volumes and conditions within each droplet with sample of regents 
demonstrating different reactions and giving better control of specificity of results (so good 
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quantitative measurements). Microdroplets also have physical advantages of using fewer 
reagents or solvent, quick turnover of mixing of reagents and samples, and it's automated and 
continuous giving higher degrees of precision and accuracy, therefore, giving identical desired 
volume microdroplets (27)(28)(29).  
  
Figure 2: referenced from (18). A complete overview of common microfluidic designs and 
methods complied together [a] droplet formation in a flow‐focusing device. [b] Droplet 
formation from jetting in a flow‐focusing device. [c] Delay line/storage area all referenced from 
(19). [d] Droplet fusion by electrocoalescence (electrical field) referenced from (20). [e] Passive, 
channel‐geometry‐mediated droplet fusion referenced from (21). [f] Electrosorting of droplets 
referenced from (22). [g] Channel‐geometry‐mediated droplet splitting referenced from (23). [h] 
Electric‐field‐induced emulsion separation referenced from (24). [i] Mixing the contents of 
droplets in a winding channel referenced from (25). [j] Droplet storage referenced from (26). 
1.4.1 Microdroplet dimensionless values. 
Within the context of microdroplet generation the following equations and dimensionless 
values Re (Reynolds number), Ca (capillary number), We (weber number) and Bo (bond 
number) are considered throughout the literature (30).  
- ‘Re’ is the inertial force (pressure from the momentum of liquid)/viscous force (the 
consistency of liquid), essentially low values of Re indicates that there will be a 
laminar flow, which is where layers of fluids will not mix and at high values of Re (at 
<4000) turbulent flow which results in fluids following irregular patterns OR mixing (31), 
in the context of microdroplet generation the Re is not completely necessary to 
consider, but is to overcome laminar flow.  
- ‘Ca’ considers the surface tension from a channel and the viscous force from a 
solution. Ca is equal to viscous force/interfacial tension (32), typically in the context of 
microfluidics the higher the capillary number the more droplets that are formed (33).  
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- ‘We’ is defined as inertial force/interfacial tension, essentially the higher the We 
number the faster the droplet formation occurs, whereas the lower the value, 
microdroplet formation is much more difficult (34).  
- Finally, ‘Bo’ which is defined as buoyancy/interfacial tension. The dimensionless 
value compares gravitational and surface forces. Often values are less than 1. Bo 
aids in characterisation of microdroplet shape (36). 
We proposed a method to produce stable monodispersed microdroplets for creating a 
supramolecular network. These values were not highly considered in the methodology as the 
microfluidic dimension and designs were based on previous successful literature, which will 
be discussed in further detail throughout the results and discussion as well as the 
experimental, however when considering new microfluidic designs, surface materials, as well 
as interfaces (e.g. oil and water) these dimensionless values are often considered throughout 
the literature.  
1.5 3D printing, microfluidics and evaluation  
To briefly universally outline what 3-D printing is; the main processes are called ‘Additive 
manufacturing (AM), Filament Deposition (FDM), and Stereolithography (SLA) which are a 
group of fabrication processes, where three-dimensional parts are constructed by adding 
layers of materials on point, line, or planar surfaces’ (37). This means that a 3-D model is 
designed in a CAD (Computer-Aided Design) file using computer software such as ‘AutoCad’, 
which slices (digitally) horizontally across the object. After the AM processes the layers and 
layers of the chosen material, it creates the physical 3-D model in a 3-D printer (38). With any 
innovative technology it has presented many advantages such as higher speed of 
manufacture, a lower cost of manufacture (due to no need for costly tools, moulds and labour). 
There was also less waste, and because the manufacturing is automated it therefore means 
a higher degree of the accuracy and precision (39). So as with all these immediate 
advantageous opportunities presented from 3-D printing, it’s natural to assume this technology 
would transfer into other fields and microfluidics is no exception. An article (40) that looked into 
the 3-D printed microfluidic devices, although there some disadvantages towards using 3-D 
printing such as ‘printer waste’ and some 3-D printers have higher rates of accuracy and 
precision/overall performance (which is varied among different types of printers). Overall the 
article concluded that it could easily replace traditional ‘soft lithography in PDMS’ as it did offer 
more or less all the advantages previously mentioned above, which present exciting 
applications within the future of chemical and biological uses. Another example that looked 
into microfluidic design biological application also concluded that it could ‘displace soft 
lithography… 3-D printing does not require extensive, high-density automation and would 
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allow biomedical scientists to have direct access to the immediate manufacture of microfluidic 
devices. (41). 
1.6 Transdisciplinary research 
As previously highlighted throughout this introduction there has been previous research into 
the creation of a supramolecular polypeptide networks and even using polyproline designs, 
however there is yet literature to be conducted for the creation of a polypeptide design network by 
utilising microfluidics (passive droplet-based in particular). The methodology discussed later 
within this thesis was heavily inspired by the article (42) published in 2016. The article managed 
to demonstrate proof of concept, between polymer supramolecular self-assembling network and 
using microfluidics. It helped demonstrate ditropic and tritropic monomers joined together using the 
CB[8] (Cucurbituril) compound to join them together (below figure 3 illustrates this). The self-
assembling supramolecular network joined together via droplet microfluidics using the water and 
oil interface which caused the Supramolecular compound to come together via self-assembly in a 
microdroplet (spherical-like structure) figure 4. Overall the article concluded a crosslinked 
supramolecular was able to develop at the interface of a droplet and was also responsive to 
chemical and UV stimuli, however the gap in knowledge within the article was the actual 
characterisation of the network such as whether the network was a bilayer, monolayer or a 
honeycomb-like structure. To reiterate this article was an important reference point for the work 
discussed throughout this thesis, as it demonstrated the use of passive microdroplet generation 
using microfluidics, creating a self-assembling supramolecular network, and although 
characterisation of the network was not achieved in that study it demonstrated the methodology 
was able to be achieved the desired results of this thesis. This study was the initial inspiration 
behind the goals of the research project that will discussed throughout this thesis. To recap, the 
overall goals and objectives of this research was create a supramolecular network via droplet 
microfluidics using a 3-D printed droplet-generating T-junction chip, at a water/oil interface. The 
aqueous phase containing polyproline and zinc would interact with the oil at the junction and form 
a  microdroplet, and the droplets would then be collected on observation glass. Over time the 
microdroplet would reduce in diameter (via evaporation) and the reduction in size would allow the 
polyproline and zinc to come together creating a self-assembly network. The network would finally 
be characterised using techniques such as DLS (dynamic light scattering) and SEM-EDX 
(Scanning Electron Microscopy - Energy Dispersive X-Ray Analysis). The possible future 
implications of this research would be biologically friendly future applications such as drug delivery 
or supramolecular catalysis.  




Figure 3: Referenced from (42). ‘(a) Chemical structures and schematic representations of 
CB[8], and the ditopic (A2) and tritopic (B3) monomers used in this work. (b) Overview of the 
proposed assembly process’ and demonstrating the networks stimuli response of UVA, heat 
and ADA.  
  
Figure 4: Referenced from (42). Outline of the assembly process from a dilute solution to an 
interfacial gel. After emulsification and electrostatic attraction, the concentration and density 
of the polymer rapidly increase as the droplet evaporates, creating the self-assembling 
supramolecular network. 
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2. Results and discussion 
2.1 Organic synthesis 
The overall goal of the organic synthetic side of the research was to synthesis a designed  
polyproline via SPPS (solid-phase peptide synthesis). More specifically a hexamer design 
(with intermediates of Fmoc-Proline-OH and a functionalised proline), the name of this design 
was simply expressed as PP6 (polyproline six), shown below at figure 5.   
 
Figure 5: Chemical structure of PP6  
 
The functional group of tert-butyl acetate was chosen as it was able to be cleaved orthogonally 
to typical condition used during SPPS, leaving behind a COO- group which would enable the 
metal coordinate zinc to join creating the self-assembly supramolecular network. Position 4 of 
proline 1,3,5 were functionalised  as this position allows the functional group to point into the 
solvent and therefore engage in supramolecular interactions. Moreover, due to the periodicity 
of polyprolines, the three non-natural amino acids will be functionalising the three different 
faces of the polyproline. Polyprolines are known to be very tolerable to functionalities. The 
focus of this work was solely on PP^ in its PPII form however, as discussed in paragraph 2.1.3, 
PP6 does show the typical CD shift expected for a short oligomer like this (peak at 225nm 
moving in the positive region). The Fmoc-pro line-OH was bought from a chemical 
manufacturer and the functionalised proline was synthesised, which is mentioned below 
throughout the results and discussion organic synthesis section as well as the experimental. 
After a sufficient amount of functionalised proline was synthesised the PP6 was synthesised 
using SPPS (solid-phase peptide synthesis), starting from a rink amide resin, then adding on 
the Fmoc-proline-OH and afterwards adding on the synthesised functionalised proline in this 
pattern was repeated until a six-chain polypeptide was synthesised. Before microfluidics was 
incorporated the hexamer polyproline was placed within a bulk alkaline solution along with a 
Zn2+ salt solution, (more specially Zn(AcO)2) which done in order to cause the self-assembly 
of the supramolecular network via a metal coordinate. The reasons for the choice of Zinc for 
the metal coordinate were as followed; Zinc is non-toxic within humans and so therefore could 
be used in biological applications (as previously mentioned for the future application of this 




which would’ve made it a good candidate in order to help characterise the Supramolecular 
network 
2.1.1 Functionalised proline Organic synthetic pathway. Discussion and analytical 
results  
 
Figure 6: Overview of initial Organic synthetic pathway, to gain the desired functionalised 




protected the alcohol group of carboxylic acid giving product (1). Reaction B was Cbz 
protection on the amine group giving product (2). Reaction C was the alkylation of the alcohol 
group, giving product (3). Reaction D was the hydrogenation to deprotect product (3) giving 
product (4). Reaction E was the Fmoc protection onto the amine group, giving product (5). 
 
Figure 6 describes the synthetic pathway that was devised in order to gain the functionalised 
proline, this reaction scheme had to be repeated on several incidents due to overall low yield 
gained. Each step had the following explanations as to why it was necessary in order to gain 
the functionalised proline:  
- Reaction A (43) was a benzylation, in order to protect the OH group of the carboxylic 
(producing an amine salt). This was done initially at the beginning in order to make 
later synthesis and purification via gradient chromatography easier. The issue with 
purification via chromatography using standard silica gel with carboxylic acids or polar 
compounds, in general, is that partitioning or the separation of the layers is less reliable 
as the polar compound will interact with the silica C-H bonds and will often remain 
within the column rather than separate out. Therefore, flushing columns is often 
required. So, it was decided in order to mitigate this effect a benzylation was carried 
out. Purification of product (1) was achieved via recrystallization and then vacuum 
dried in an oven. Average yield 80.3% (reaction was preformed three times 82%, 78%, 
81%).  
 
- Reaction B (44) was a Cbz protection reaction, which was used to protect the amine 
group of the proline. This was done for two reasons, the obvious reason being to 
protect the amine group from reacting with reagents later in the synthetic steps and 
the other reasons being that at reaction C (alkylation) involves a strong base and Cbz 
doesn’t react with the base and remains stable under the conditions used. Purification 
of product (2) was achieved via gradient column chromatography using 6:4 petroleum 
ether and ethyl acetate with a Rf value of 0.35.  Average yield 79.0% (reaction was 
repeated twice 75% and 83%)  
 
- Reaction C (45) was an alkylation reaction, in which a tert butyl acetate was added to 
the OH group of the proline, this was done in order to function as the point at which 
metal coordinate would self-assemble, joining the hexamer polyproline to create the 
supramolecular network. Product (3) was purified via gradient column 
chromatography again using 7:3 petroleum ether and ethyl acetate with a Rf value of 





- Reaction D (46) was a hydrogenation reaction to simply remove the two protection 
groups of the benzyl group on the carboxylic acid and the Cbz on the amine group. No 
purification of product (4) was required. Average yield 92.5%. (93 and 92 reaction 
performed twice).  
 
- Reaction E (47) finally was the Fmoc protection, to protect the amine group. This was 
done because the SPPS design of the hexamer involved Fmoc chemistry. which 
involves the cleavage of Fmoc using a specified mixture of reagents, in order to couple 
with an amino acid creating the sequence of the polypeptide chain. Purification of 
product (5) was at first tried to be achieved via recrystallization by a small volume of 
diethyl ether, large volume of petroleum ether, and then placed within the freezer 
overnight. However, product (5) didn’t precipitate out into solution, so therefore 
column chromatography was used (9:1 DCM and methanol, giving a Rf value of 0.4) 
and then followed by flushing the column with methanol. Average yield 35.0% (37 and 
35, 33 reaction performed three times).   
Product (1), the benzylation reaction with the starting material of trans-hydroxyl proline, the 
product was characterised using 1H NMR, IR and LCMS after the product was purified via 
recrystallization after being washed diethyl ether, filtered and then washed again with ether 
and finally dried in a vacuum oven. The 1H NMR and IR were to confirm the presence of the 
amine salt p-Toluenesulfonic acid, which can be observed below at appendix 1 and 2. The 
LCMS spectra confirmed the expected molecular mass of the compound being m/z 393. 
 
Product (2) was purified via gradient chromatography, dried under high vacuum and analysed 
with 1H NMR, IR and LCMS. Initially, 1H NMR demonstrated that the 1st attempt at purification 
via column chromatography using the system of 6:4 Petroleum ether to ethyl acetate was 
somewhat thwarted by an issue regarding the petroleum ether solvent. The petroleum ether 
solvent purchased was of ‘analytical grade’, however it gave ‘grease’ peaks at the lower 
chemical shift regions, which is what appendix 3 demonstrates, as well as the 1H NMR spectra 
of the ‘analytical grade’ petroleum ether shown at appendix 4. After changing the solvent of 
petroleum ether to ‘Laboratory-grade’, this appeared to mitigate the issue, as demonstrated 
by the 1H NMR at appendix 5. After gradient column purification and the product being dried 
once again, this gave little to no peaks of ‘grease’. The 1H NMR and IR spectrum were used 
to confirm the presence of the Cbz protection group which is shown at appendix 5 and 6. 





Reaction C presented an issue of creating a diastereomers shown below at figure 7 This was 
suspected as when a TLC was taken using the system of 7:3 Petroleum ether:ethyl acetate 




Figure 7: The suspected structures of the diasteroisomers, product 1 being the trans (S) 
configuration and 2 being Cis (R) configuration.  
 
In order to gain a purified Product (3) gradient column chromatography was required. 1H and 
13C NMR, IR and LCMS spectra were recorded and then polarimeter were performed after 
the chromatography column was performed. First the appropriate set of fractions were 
collected and dried, a polarimeter reading was taken of the two suspected Product 3 fractions 
that had very similar Rf values of 0.35. Both compounds were dissolved in solution giving a 
concentration value of 1. One solution gave a reading of -00.32 and the other +00.28 which 
after the values were times by 100 gave an ‘αD’ (alpha d) value of -32 and +28. The negative 
value strongly suggests that a compound is of trans configuration and the positive value 
strongly suggests Cis. Product (3) was highly likely to be the negative αD value set of fractions. 
Product (3) was analysed using 1H NMR spectra (appendix 7), which showed the 
characteristic peaks of the tert-butyl acetate group at the singlet peak at the 1.47 ppm chemical 
shift region, indicating the presence of the three CH3 groups. 13C NMR spectra were taken to 
show the number of carbons present on product (3) which is 23 which is the number of peaks 
present in the 13C spectra (appendix 8). IR spectra at appendix 9 the wavelengths help 
indicate the presence of the functional groups so the tetra butyl acetate, Cbz and the amine 
salt. Finally, LCMS was used to confirm the molecular mass which was expected to be m/z 
470.5.  
 
Product (4), 1H NMR, IR and LCMS spectra was taken, both the 1H NMR and IR analysis was 





NMR had gone. At appendix 10 and appendix 11 indicates the peaks and wavelengths of 
Cbz and benzyl group within the aromatic regions had gone and therefore the hydrogenation 
was successful in deprotecting product (3), removing the Cbz and benzyl group. The LCMS 
was used to confirm the molecular mass which was expected to be m/z 246.3.  
  
Finally, product (5) 1H, 13C NMR, IR, LCMS spectrum and Polarimeter was taken after gradient 
and flash chromatography and dried under high vacuum. The 1H NMR and IR spectrum shown 
at appendix 12 and 13 simply shown the peaks within the aromatic region indicating that 
Fmoc had joined and protected the amine group of product (4). 26 carbon atoms are present 
on product 5 and the number of peaks consolidates with this number at appendix 14. LCMS 
was used to confirm the molecular mass which was suspected to be roughly m/z 468.5. The 
compound was dissolved and had a concentration of 0.8, The polarimeter reading a negative 
reading of -00.22 which after being times by 100 and then divided by 0.8 gave an αD value of 
-27.5 indicating that it was the desired trans optical configuration.  
2.1.2 SPPS Hexamer PP6 design. Discussion and analytical results 
 
Figure 8: Overview reaction of SPPS synthesising the hexamer PP6 design.  
 
Once enough of product (5), functionalised proline was synthesised, PP6 was then 
synthesised. The overview of the SPPS reaction is demonstrated at figure 8. The 
methodology procedure of SPPS (48) were as followed; 




- The 1st coupling mixture was added consisting of commercially bought Fmoc-Proline-
OH, pyBop, HoBt and DIPEA.  
- An aliquot of the resin beads was taken and the kaiser test was then employed to 
check for primary amines if the beads remained colourless then the coupling was 
successful.  
- Capping mixture was added which consisted of 10:2.5:100 Ac2O, DIPEA and DMF to 
mop up any remaining free amines 
- Once again, an aliquot of the resin beads was taken and the kaiser test was 
deployed. SO, the first coupling had been completed.  
- The deprotection mixture was added again to deprotect the Fmoc-proline, after which 
the coupling mixture consisting of the synthesised functionalised proline, pyBop, 
HoBt and DIPEA was added. 
- An aliquot of the resin beads was taken, and the chlorophyll test was then deployed, 
to test for free secondary amines. If the beads were colourless then the coupling was 
successful.  
- The coupling was repeated four more times, with intermediate changing of the proline 
with the coupling mixture until the desired hexamer PP6 design was achieved. 
(figure 9 shows the chemical structure of the PP6 design and 3-D top-side and side 






Figure 9: Chemical structure of hexamer PP6. 3-D model of polyproline showing the top-view 
and side-view. (Model was generated by optimised geometry calculated with MOPAC software 
at the PM6 level, confirmed as a minimum by frequency analysis).  
 
After the final coupling had been completed the cleavage reaction from the rink resin was then 
performed (48)(49), the cleavage mixture consisting of 88% TFA, 5 % DTT (Dithiothreitol), 5% 
TIPS (triisopropylsilyl), and 2% water which was added to the resin containing the PP6 design. 
The cleavage solution was slowly dripped into a cold solvent of diethyl ether, causing the PP6 
hexamer to crash out into a white precipitate. The solution with the precipitate was centrifuged 
and decanted, washed with diethyl ether and decanted again. Finally, the solid was dried 
under vacuum. 
 
The solid product was comprehensively analysed using 1H, 13C NMR, LCMS, IR spectra and 
then a CD (circular dichroism) was taken in solution, which Is demonstrated at appendix 15, 
16, 17, 18 and figure 10. The Combination of the spectrum analytical techniques such as the 
1H, 13C gave chemical shift peaks helping to demonstrate the structure of the hexamer 
polyproline design and LCMS helped cement the predicted molecular mass (863 m/z) of the 
desired polyproline design. The LC retention time spectra was also used to measure the purity, 
and the spectra showed an asymmetrical peak with a very slight ‘shoulder’ peak possibly 
indicating a slight impurity. However, overall the peak purity of the ‘main’ peak suspected to 
be PP6 was 92-93%. The type of polyproline that was aimed for in this research was PP II in 
solution, and the CD spectra was used to confirm this as the data gained was compared to a 
known database of polyproline II. The polyproline was dissolved in TFE and the CD (figure 
10) gained matched the known database value of PP II, as well as an IR spectrum (appendix 





Figure 10: CD spectra of PP6 dissolved in TFE solution, indicating PP II confirmation.  
2.1.3 PP II to PP I in Propanol  
One of the future desired applications of this project was for biological friendly applications, 
such as drug delivery. The way in which this was theorised to be achieved was that PP I (which 
is much more of a compact closed structure of polyproline consisting of cis configuration 
compared to the PP II) would create the supramolecular network and slowly convert into PP 
II which is a less compact structure. What this is means is that as the PP I would slowly convert 
into PP II, which would cause a time delay in which the therapeutic substances are being 
released, thus reaching to the desired targeted areas within the body. In literature it’s been 
documented that apolar solvents such as propanol at low temperatures (5 oC) have influenced 
changing the conformation of PP II to PP I (50). This was replicated in this research, the 
hexamer PP6 was dissolved in propanol and was left in the fridge over the course of 5 days. 
After which a CD was taken as well as IR. The CD spectra of PP6 in TFE and propanol is 
reported below figure 11. These spectra were recorded at the same concentration therefore 
it is clear that there are significant differences between the two species. This would suggest 
in agreement to the literature (50) that a PPII to PPI transition did occurred in propanol. However 





Figure 11: CD spectra overlap of PP6 in TFE indicated by red line and the PP6 in propanol  
2.1.4 Proof of concept, PP6 and zinc joining in bulk solution. Discussion and analytical 
results.  
A proof of concept for PP6 in solution to join with a metal coordinate was attempted in order 
to demonstrate that a supramolecular network could be formed, before the implementation of 
the micof2.1luidic aspect of the research project. PP6 was dissolved in ultra-pure water with 
NaOH and D2O giving a 0.1 M solution. 1 M of Zn(OAc)2 D2O solution added intermediately 
two times. 1H NMR, DLS and SEM-EDX were taken before the addition of the Zn(OAc)2 
solution and after the two increments of the Zn(OAc)2 solution. The NMR results (figure 12, 
13, and 14) were very ambiguous there only slight changes within the 2.0 – 4.0 ppm (parts 
per million) chemical shift region, but overall the results were not strong enough to suggest 





Figure 12: 1H NMR spectra PP6 in saturated NaOH with D2O solution. 
 




Figure 14: 1H NMR spectra PP6 2nd addition Zn(OAc)2 D2O solution 
The combined DLS size distribution data shown at figure 15 was far more promising 
demonstrating supramolecular network formation. DLS was used to determine the 
hydrodynamic diameter of particles, and the supramolecular formation would be indicated as 
the Zn(OAc)2 would be added the hydrodynamic size should increase, and this was consistent 
by the shift increase in diameter on the DLS spectra from the blue lined peak to the dotted red 
and green lined peaks strongly indicating the supramolecular formation of the Zn(OAc)2 the 
PP6. To further cement this data, The dotted purple lined peak at the DLS spectra figure 15 
demonstrated a lowered shift in diameter by the introduction of the chelating agent of EDTA 
(Ethylenediaminetetraacetic acid), which reacted with zinc to form a complex breaking up the 





Figure 15: DLS of PP6 (blue line), PP6_1Zn (red dotted line), PP6_2Zn (green dotted line) 
and PP6_2Zn+EDTA (purple dotted line). DLS helped provide proof PP6 was promoting the 
formation of a supramolecular polymer with the Zinc coordinate, which is then broken up by a 
chelating agent dissolved in water.  
 
The SEM-EDX data images also were exciting and helped support the DLS data. Below at 
figure 16 shows the topography progression after each addition of Zn(OAc)2. At figure 16 (a) 
is the SEM image and (b) is the EDX. Figure 16 shows the homogenous distribution of the 
PP6. At (c) showing the SEM image, (d) and (e) showing the EDX image at figure 16 shows 
the pockets of spheres forming after the first equivalent of the Zn(OAc)2 solution was added. 
Finally, at (f), (g) and (h) figure 16 after the second equivalent of Zn(OAc)2 was added a skin 
like spherical film had formed, indicating a supramolecular network had been created. Once 
again helping to support that a self-assembly had occurred between the PP6 and zinc 
coordinate. This experiment demonstrated the responsive nature of the PP6_Zn1 and 
PP6_Zn2 supramolecular polymers. Overall both the SEM-EDX and DLS data strongly 
indicated the formation of the supramolecular network, which in turn helped provide the proof 
of concept that the formation was possible and supporting the possibility of the microfluidic 




































Figure 16: (a) SEM images of the PP6, with the carbon adhesive disc. (b) EDX image of PP6 
with blue indicating nitrogen. (c) PP6_1Zn SEM image, pockets of supramolecular spheres 
being formed. (d) and (e) EDX image both the blue and orange colour indicating the nitrogen 
with spheres of black formed indicating supramolecular sphere formed. (f) PP6_2Zn SEM 
image, of supramolecular network forming a skin-like surface, which is highlighted by the 
green dotted line. (g) and (h) EDX analysis once again demonstrating the outline shape of the 
supramolecular network formed. (In the skin-like section marked with green dots at (f) Zn is 
still present, the sample was placed on top of a carbon support and we predicted that the 
polymer was extremely thin and therefore a very weak signal you see in panel (h)). 
2.2 Microfluidics  
The second component of this research was the incorporation of microfluidics in order to 
generate monodisperse microdroplets via emulsion at the aqueous and oil (with surfactant) 
interface. Therefore, bringing the PP6 and chosen metal together creating the self-assembling 
supramolecular network. At figure 17 shows the overview diagram of how the supramolecular 
network was theorised to be formed. The concept was inspired originally by the reference (54) 
mentioned previously in section 1.8. Throughout this section, the brief overview of the 
methodology and the chip designs will be discussed as well as the results gained from the 




in section 1.5.1 were not considered throughout the methodology as the dimensions and 
flowrate were based on the previous literature successful designs.  






Figure 17: diagram of a representative microscopic image showing microdroplets emulsify 
and evaporated over time shrinking the diameter of the sphere and creating self-assembling 
of polyproline with zinc.   
2.2.1 Design and manufacture of Microfluidic chips  
As mentioned previously in section 1.6, 3-D printing has had become more and more of a 
popularised technique used within several STEM field industries, due to the increased 
reliability and accuracy over the last two decades. So, 3-D printing was decided to be utilised 
in the design and manufacturing of microfluidic chips. Auto-Cad was the 3-D computational 
software that was used in order to design the microfluidic chips, and three chip designs were 
considered. Shown at figure 18 were the rough schematics of the main designs; ‘T’ junction 






















Figure 18: Microfluidic chip schematics. (A) ‘X’ junction microfluidic chip. (B) ‘T’ junction 
microfluidic chip. (C) ‘Y’ junction ‘Zig-zag’ microfluidic chip. With each Input and output ports 
labelled.  
 
The auto CAD designs of the chips were exported to the 3-D printer software known as ‘form 
labs 2 PreForm’, after which the designs were printed at 0.025 mm resolution using the ‘Form 
labs 2’ 3-D printer. At figure 19 are the resin chip designs after they have been printed and 
cured via UV radiation. PDMS and curing agent was then poured on top of the resin chip and 
left to cure in an oven to create the PDMS mould. After which the PDMS mould casting was 
plasma cleaned onto a glass surface, (oxidises the surfaces and then an electrode creates 
free radicals onto the glass and PDMS mould surfaces) after each of the surfaces were gently 
pressed on top of each other forming a very tight seal. The results of the manufacture of the 
plasma cleaned microfluidic chips is shown at figure 20. 
   
 
Figure 19: Microfluidic UV cured resin chips. (A) ‘X’ junction microfluidic chip. (B) ‘T’ junction 
microfluidic chip. (C) ‘Y’ junction ‘Zig-zag’ microfluidic chip. With scale bar.  
(A) (B) (C) 










     
 
 
Figure 20: Plasma cleaned microfluidic chip designs on glass slides. (A) ‘X’ junction 
microfluidic chip. (B) ‘T’ junction microfluidic chip. (C) ‘Y’ junction ‘Zig-zag’ microfluidic chip. 
With Scale bar.  
 
The key dimensions of the microfluidic channels were the height of the channels being 0.1 
mm (100 micrometres), and the width was 0.2 mm (200 micrometres) and 0.1 mm at the pinch 
of the junctions of the ‘X’ and ‘T’ designs based on literature (54). Below at figure 21 shows the 
microscopic image of the microfluidic channel designs. At (A) and (B) at figure 21 Both were 
used for passive cross junction microdroplet manipulation. What this means is that when the 
aqueous and oil phase (with surfactant) cross met, it created emulsion, and formed 
microdroplets. The mixing zig-zag design which is shown at figure 21 (C) was manufactured 
in order to mix the zinc and PP6 compound on the microfluidic chip itself rather than mixing in 
a bulk solution, the ideal set-up is shown at figure 22. This was done to more accurately mix 
the zinc and PP6 in order to prevent having a big collocate molecule before getting to the 
cross junction of the ‘X’ or ‘T’ chip, as the idea was that the supramolecular network comes 
together within the microdroplets in a spherical manner.  










Figure 21: Microscopic image of ‘X’ junction with a red circle highlighting ‘pinch’ at (A). ‘T’ 
junction with a red circle highlighting ‘pinch’ at (B). ‘Y’ junction with ‘zig-zag’ design at (C). With 
scale bar.  
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Figure 22: schematics of example ideal set-up. Mixture chip with two inputs of Zinc and 
aqueous containing PP6 design. The outlet of mixture chip connected to the input of the ‘X’ 
junction chip. 
2.2.2 Issue of leakage, design of inputs and outputs 
The first beta designs of the microfluidic chips of the junction and the mixing designs had 
different input and output designs. Initially, a wide blue ‘adapter’ was inserted directly within 
the inputs and outputs on top of the glass surface, this was done in order to have a ‘plug-and-
play’ element. This caused huge pressure within the microfluidic chip and caused a big issue 
of leakage, despite the slow flow-rates of the syringe pump at 1-10 microlitres per minute or 
10-100 microlitres per hour, this still caused leakage often in the inputs, an example of this is 
shown below at figure 23. Two main issues would arise as a result of leakage, the first being 
that only a very small quantity of the aqueous phase would be available, therefore this issue 
would lose an excessive amount of valuable material. The second being when it came to 
generating monodisperse microdroplets this would also be an issue, as there is not a constant 
flow, therefore disrupting the consistency of the spherical microdroplet shapes.  
   
Figure 23: Photos of blue adaptor leakage demonstrated by the red circle.  
 
In order to mitigate this issue of leakage, the blue adaptor as shown above in figure 23 was 
replaced, and the inputs and outputs would be designed centred around the ‘Omnifit™’ screws 
which are shown below at figure 24 These screws were the outlet in which the fluids would 
exit from the tubing. The screws were significantly smaller in diameter compared to the blue 
adaptor; therefore, reducing backpressure significantly. The other design iterations that were 
taken into consideration was the omifit screw would fit tightly within the Inputs and outputs, as 




rather fit tightly above the glass, also reducing a lot of backpressures as well as leakage. The 
dimensions of the omifit were considered by designing the bottom half of the inputs and 
outputs as 3.8 mm at the bottom half and 4.3 mm at the top half in diameter. Below at figure 
25 is the AutoCAD cylinder shape designed input and outlet shape. 
   
Figure 24: microscope image of Front and side view of the omifit screw.  
      
Figure 25: The dimensions of the omifit inputs and outputs. Cylinder shape, the top half having 
a wider diameter of 4.3 mm and the bottom half being 3.8 mm in diameter.  
 
Overall this reduced leakage significantly, as the tight fit and the omifit placement above the 
glass at the 4.3 mm diameter (figure 26) caused a steady flow when the syringe pumps were 
turned on. At figure 27 shows an example of the difference between the inputs and outputs 
on PDMS casted plasma cleaned chips. However, one issue that was become evident after 




this presented an issue of causing a loosening and widening of the PDMS inputs and outputs, 
which in turn lessened the tight fit and sometimes caused leakage. Therefore, new microfluidic 
PDMS plasma cleaned chips had to be manufactured every 5-10 uses.  
 
Figure 26: A photo of the omifit inserted in the new designed input and output side-on.  
    
Figure 27: Photo of plasma cleaned beta and final ‘X’ junction design chips, with redesign 
before and after of inlets and outlets indicated by the red circle.  As well as reduction in overall 
microfluidic channel length.  
2.2.3 Mixing Chip. Discussion and results 
As discussed briefly in section 2.2.2, the mixing chip was manufactured in order to mix the 
zinc solution and the PP6 solution together within the microfluidic channels forming the 




demonstrated success. The idea behind this design was to have enough surface area and 
ridges for two different fluids to interact with each other and overcome the laminar flow. The 
overall dimensions of the mixing chip channels were as followed; 0.1 mm in height and width, 
between each zigzag ‘step’ was 0.4 mm distance them, and the overall length of the whole 
channel was roughly 2 cm. Below at figure 28 demonstrates these dimensions.  
  
Figure 28: Microscopic image showing dimensions of zig-zag design.  
 
The mixing chip was tested by pumping two separate syringes with two different food colouring 
of red and blue diluted with ultra-pure water at 10-120 microliters per minute and the results 
expected where for the colour purple to be observed down the channel as reference in the 
literature (53). However, this didn’t occur and unfortunately the design was unsuccessful in 
mixing. Instead the microfluidic device produced laminar flow and the two food colouring fluids 
laid on top of each other (figure 29) which was also reported in the literature referenced. 
Despite the literature the results were not successful. Due to time constraints further 
optimisation/refinement and further research weren’t able to be conducted. Mixing chip was 
not required for this project but will be used in future work within the final product of this project.  
Steps 
0.4 mm 
Overall length 2 cm  
Height - 0.1 mm 
Width – 0.1 mm 





Figure 29: Microscopic image of the ‘zigzag’ mixing microfluidic the red and blue expressing 
laminar flow.  
2.2.4 Microdroplets generation. Water and oil/surfactant  
The ‘X’ and ‘T’ junction designs were initially tested with ultra-pure water with red food dye 
colouring and silicone oil with span 80 (surfactant) to generate microdroplets. Water was 
pumped at a constant rate at 15 microlitres per minute and the oil with surfactant was pumped 
at various rates at 30-120 microlitres per minute. The results were successful both the ‘X and 
‘T’ chips both produced microdroplets, which is shown below at figure 30 and an example of 
microdroplets being formed at outlets from both the ‘X’ and ‘T’ junction is shown at figure 31  





   
 
Figure 30: (A) ‘X’ junction microscopic images taken showing microdroplet generation at the 
‘pinch’ of the junction. (B) T’ junction microscopic images showing microdroplet generation at 
the junction.   
   
 
Figure 31: (A) microscopic image of ‘T’ junction microdroplet accumulation at the outlet. (B) 
microscopic image of ‘X’ junction microdroplet accumulation at the outlet.  
 
The microfluidic chips of both the ‘X’ and ‘T’ junctions were then tested using fluorinated 
oil/surfactant, first the channels were fluorinated using fluorinated silane in FC-40 and then 
was left to cure overnight in the oven at 120o C. ultra-pure water and FC-40 oil with sphere 
fluidics Pico surf fluorinated surfactant were pumped at the same rates as mentioned 
previously with the initial tests using the silicone oil, the chips also generated microdroplets 
using these fluorinated chemicals. The reason why fluorinated oil chemicals were used was 
because of five reasons, Fluorinated chemicals are biocompatible, commonly organic 
compounds are insoluble in fluorinated substances, fluorinated chemicals are almost 
completely inert so therefore are also compatible with many surface material so they don’t 







microdroplet generation (55). However, one of the most desired reason is that fluorinated 
oil/surfactant are denser than water, Droplets on the liquid surface is advantageous as it 
increases the rate of evaporation. Increased evaporation aids in the formation of the 
supramolecular network.  
 
Overall the microdroplet generation was able to be achieved by using both the ‘X’ and ‘T’ 
junction, but monodisperse droplets wasn’t achieved by the ‘X’ junction but more accurately 
by the ‘T’ junction. Monodisperse droplets were critical in order to provide a more accurate 
insight into seeing whether the supramolecular network had been formed by having identical 
sized microdroplets. The microdroplet formed from both chips went up the Omnifit™ in the 
tubing (example Shown at figure 32) and then microdroplets were collected onto glass slides 
containing fc-40 shown at figure 33 However, the big issue both microdroplets collected 
presented was that neither of them remained stable for a long enough period of time, this will 
be discussed more in detail in section 2.2.7 of this thesis.  
 




    
 
Figure 33: Microscopic image of droplets on a glass slide. (A) microdroplets formed from the 
‘T’ junction chip. (B) microdroplets formed from the ‘X’ junction chip.  
2.2.5 Microdroplets generation. Propanol and oil/surfactant 
As mentioned throughout this thesis, one of the future ambitions of this project would be for 
the supramolecular network to be applied to biological application such as delivery of 
therapeutic substances, and the method of how this research would impact on that goal would 
be that an apolar solvent such as propanol at low temperature would convert PP II to PP I. As 
mentioned, PP I has a more closed compact structure (cis configuration) compared to PP II 
(trans configuration), overtime the PP I supramolecular network would slowly convert back to 
the PP II supramolecular network, causing a delay in the release of therapeutic substances. 
As a proof of concept, the microdroplet generation was attempted with propanol (coloured with 
red food dye) and fluorinated oil with surfactant with the syringe pump flow rates set at the 
same rates as previously mentioned at section 2.2.4 of this thesis. Only the ‘T’ junction chip 
was used as it generated the most consistently sized microdroplets. The results were not as 
successful as shown below at figure 34. The microdroplets didn’t form emulsion at the ‘T’ 
junction but instead produced laminar flow and didn’t produce microdroplets until at the ‘pinch’ 







Figure 34: microscopic image of ‘T’ junction attempt at microdroplet generation with propanol 
and fluorinated oil with surfactant.  
 
In the context of passive microfluidic microdroplets generation with PDMS casted microfluidic 
chip, the organics solvent and oil interface is a field that hasn’t been researched thoroughly 
yet. Organic solvent in PDMS has reported issues of swelling and only have been 
demonstrated in etched silicon plates. There have been methods worked around to introduce 
organic solvents one example was inserting organic pendants/vesicles inside of aqueous 
phases (56) or there has been success in droplet generation with non-aqueous phases involving 
‘digital’ microfluidics by applying an electric current in the microfluidic channels (57). However 
overall there hasn’t been much-demonstrated literature for passive microfluidics, so other 
methodologies avenues needed to be explored in order to achieve the future ambitions from 
this thesis.  
2.2.6 Microdroplet stabilisation.  
Overall the microdroplet droplet generation at the water and oil/surfactant interface using both 
the ‘X’ and ‘T’ junction was successful, but both didn’t create stable droplets (typically 10 
seconds before they merge which is not the behaviour expected for stabilized droplet). The 
‘X’ junction chip didn’t achieve monodisperse droplets, however, the droplets produced were 
stable for a longer period of time than compared to the ‘T’ junction chip. The microdroplets 
formed at the outlets of both designs appeared to remain stable as previously shown at figure 
33 however, the droplets appeared coalesce traversing the Omnifit™ screw fitting and tubing. 
Although not always, however the droplets would eventually coalesce on the glass slide, an 




   
Figure 35: microscopic image of the microdroplets. The microdroplets beginning to coalesce 
on the right-hand image.  
 
The period of time of microdroplets emulsion wasn’t sufficient to be applied to the creation of 
the supramolecular network. In the ideal conditions, the microdroplets would remain stable 
and over time the aqueous phase would evaporate, after which an emulsion breaker would 
be added and observed under the microscope observing an indication of the supramolecular 
network, this, however, was not the case. There were two suspected design flaws with the 
‘X’ and ‘T’ junction microfluidic chips, the first being the overall length of the devices to the 
output was too long, possibly the microdroplets dealing with surface tension from the PDMS 
over a longer length of time could’ve disrupted the stability. The second flaw was the omifit 
fitted in the outlet of the microfluidic devices, the accumulation of the microdroplets forming 
at the outlet would accumulate until the pressure would push an influx of microdroplets up 
the omifit into the tubing, as shown previously above in section 2.2.4 at figure 31. The 
pressure acting upon the microdroplets due to the change in volumes using Omnifit™ may 
have caused coalesce within the tubing before deposition on a glass slide. Two Other 
suspected issues that failed to create stable droplets were the use of two different 
mechanical coil-based syringe pumps, which caused very slight delays in either the oil or 
water phases, so therefore would not maintain a constant flow and would disrupt the 
consistency of the size of the droplets which may have also perhaps disrupted the stability. 
The other issue being that according to the manufacturer of the ‘pico surf surfactant’, the 
surfactant was optimised to work best within 0.4 mm or less in diameter to create stable 
droplets, and the Omnifit™ tubing was 2 mm in diameter. So, the two desired redesign of the 
junction chips if more time was allocated within this research would be to the insert of the 
tubing directly into the PDMS and to be cured, so no accumulation of the droplets would 
occur at the outlet and each microdroplet would immediately travel up the tubing reducing 
the variation of pressure. An overall reduction of the travel time to the pinches of the ‘X’ and 




would cause significantly less delay and higher consistency in flow rates as well as using 




3. Conclusion  
In summary, for the organic chemistry component of this thesis, it has been demonstrated that 
a synthetic pathway gained a functionalised proline, which in turn that proline was utilised in 
SPPS to synthesis PP6. The PP6 was able to dissolve into organic solvent such as TFE, able 
to dissolve into water (with small 2% addition of methanol) and was able to be dissolve into 
alkaline water solution (H2O with NaOH). The analysis of DLS and SEM-EDX helped 
demonstrated that a supramolecular network was able to be formed within a bulk solution with  
overall the organic synthesis side of the research was relatively successful (with the synthetic 
pathway overall yield being an exception to be improved). The ability to form a number of 
different morphologies using one simple hexamer is remarkable and will be further 
investigated in the Palma group. For the microfluidic component of this thesis it has been 
demonstrated that microdroplet generation at the aqueous and oil (with and without surfactant) 
interface was performed with two different designs (‘X’ and ‘T’ junction) manufactured from 3-
D printed mould fabrication to PDMS microfluidic device. Although the demonstrated results 
from this thesis are novel, the final desired result of incorporation of both components to create 
the supramolecular network was unfortunately superseded by the instability of the 
microdroplets. The results from the proof of concept for the formation of the supramolecular 
network in a bulk solution were promising and future analytical data would be desired to be 
collected using techniques such as AFM (giving the topography of the structure) and neutron 
scattering (characteristic peak of zinc) to further support supramolecular formation.  Overall 
prioritisation of the redesign of the microfluidic junction chips was required to order to create 
the desired microdroplet supramolecular network. The results gained from this research was 
a precursor and able to lay foundations for future work. Only slight increment alterations to 






4. Future work 
There were several aspects of this research that were highly desired to be improved upon for 
future work such as;  
- Optimisation of the synthetic pathway to gaining the final functionalised proline to 
improve the yield.  
- Characterisation of the microdroplets using a measurement operation software.  
- To further support the proof of concept using AFM and neutron scattering, as well as 
trying different zinc derivatives or biologically friendly metal coordinate derivatives.  
- Future researching and testing different apolar solvents or methodology to convert 
the functionalised PP II to PP I for future ambition work mentioned at section 2.2.4.  
- Design, Manufacture and test other mixing chip designs, to overcome the laminar 
flow.  
However, the priority future work to be conducted from this thesis was the supramolecular 
assembly demonstration via microdroplet manipulation which was the end goal when setting 
out on this thesis, this, however, wasn’t able to be achieved. Due to time constraints, the 
appropriate optimisation of design for the microfluidic junction chips was an issue. The critical 
redesigns would be the accommodation of the tubing at the outlet rather than the omnifit. 
overall the constant flow from the omnifits placed in the inlets was sufficient to create the 
microdroplets, however the omnifits at the outlet not only caused unknown pressures for the 
influx of droplets to go upwards into the tubing, but it also caused an accumulation to form a 
‘pool’ of microdroplets. Ideally the redesign would involve the direct embedding of the tubing. 
The direct embedding would allow the droplets to go directly into the tubing rather than 
accumulate in a pool of droplets and dealing with unknown changing pressures. These future 
work redesigns as mentioned would ideally increase the stability of the emulsified 
microdroplets and would allow the demonstration of the microdroplet supramolecular network. 
Ideally in future work the monodisperse microdroplets would be generated using the 
fluorinated chemicals, consisting of the FC-40 and 2 % fluorinated surfactant, the droplets 
would be collected and then left to dry after which the fluorinated emulsion breaker of 








5. Experimental  
5.1 Organic synthesis  
Below is the experimental containing the quantities, equivalences and methodology of the 
organic synthesis of the synthetic pathway, gaining the functionalised proline and SPPS PP6 
design. All the Gradient Flash Column Chromatography was performed on high purity grade 
silica gel particle size 75-150 μm. All NMR spectra were recorded at room temperature on a 
Bruker 400 MHz which operated at 100 MHz or 400 MHz for 1H and 13C analysis. Chemical 
shifts (δ) units are parts per million (ppm) relative to the deuterated solvent signal (1H: D2O, δ 
4.79 ppm; CDCl3D, δ 7.24 ppm), (13C: CDCl3D δ 77.0). The splitting patterns were 
characterised as s (singlet), d (doublet), t (triplet), m (multiplet). Liquid chromatography 
Electrospray ionization mass spectroscopy was performed at low resolution using the UltiMate 
3000 from thermo fisher scientific. FTIR (Fourier-transform infrared spectroscopy) with an 
attenuated total reflectance (ATR) attachment was performed measuring the bonds 
wavelengths at cm-1. Angle of rotation was measured using a digital polarimeter gaining the 
αD. Solvent were removed from products using a rotavapor based on a preprogramed 
database of optimal pressures and temperatures, after which all crudes and purified products 
were dried under the continuous high vacuum setting of the rotavapor. All deuterated solvents, 
solvents and reagents for the reactions below described, were purchased commercially from 
trusted chemical dispensers; fisher scientific, sigma and fluorochem. All chemicals were 
presumed to be of the highest quality according to the manufacturer. 
5.1.1 Synthetic pathway synthesis  
As prior mentioned in the results and discussions at section 2.1.1 and at figure 5 shows the 
overview, justifications and results of each reaction. Within this section is the quantities, 
techniques and observations for each reaction for the pathway. This reaction pathway from 
reaction B onwards was repeated due to the overall low yield gained at the final step, to 
prevent repetition within this experimental, the reactions described below are represented of 
typically what the reaction would result in.  
 
1. Reaction A: Reagents trans-4-Hydroxy-L-proline (1 eq, 114.4 mmol), p-
Toluenesulfonic acid monohydrate (1 eq, 114.4 mmol). Solvents toluene (134 ml), 






- Weight 15 g of trans-4-Hydroxy-L-proline and made up a solution of 134 ml 
toluene and 134 ml benzyl alcohol. Weight 21.8 g of p-Toluenesulfonic acid 
monohydrate and added to starting material solution. Mixed and placed under reflux 
at 125oC for 20 hours, also using a dean stark trap to remove the water. After 20 
hours the reaction is cooled down to room temperature and the product is crystallised 
using cold diethyl ether (800 ml). After 30 minutes the oil becomes a white 
precipitate. Solid is collected via filtration and washed with ether (250 ml) and dried 
in a vacuum oven overnight. 36 g of solid white powder was gained product (1) 
(2S,4R)-2-((benzyloxy)carbonyl)-4-hydroxypyrrolidin-1-ium) Yield 80%. This was 
the purified product and was carried forward onwards to the next reaction.  
 
- NMR spectroscopy: 1H NMR (CDCl3D): δ(ppm) 2.35 (m, 3H), 2.5 (m, 1H), 5.2 (d, 
1H) 
7.1-7.7 (d and m, aromatic H).  
- Mass spectrometry: ESI-MS(m/z):[M-H]+calcd.forC12H16NO3+C7H8O3-, 393.1;found, 
393.45 
- IR spectroscopy: FT-IR (ATR) ν: 592, 893, 1093, 1193, 1294, 1494, 1595, 2297 
cm1.  
 
2. Reaction B: Reagents product (1) (dibenzyl (2S,4R)-4-hydroxypyrrolidine-1,2-
dicarboxylate) (1 eq, 12.7 mmol) Benzyl chloroformate (1.18 equivalent, 15.012 






- Weighted 5 g of product (1) ((2S,4R)-2-((benzyloxy)carbonyl)-4-
hydroxypyrrolidin-1-ium), added 64 ml of tetrahydrofuran and 64 ml of sodium 
bicarbonate stirred for 10 minutes at room temperature and stirred at 0 o C. Add 2.17 
ml Benzyl chloroformate to the solution and left to stir for 1 hour. the reaction was 
quenched with 3 M HCl at 0 o C, check pH to acidic. Reaction was extracted with 
DCM and wash with brine. Dry solution with MgSO4 till the solution became clear. 
Filter and dried in the rotavap until a yellowish oil formed. The compound was 
purified by silica gel column chromatography using hexane/EtOAc 6:4 using a 
gradient system. 4.5 g of product (2) (dibenzyl (2S,4R)-4-hydroxypyrrolidine-1,2-
dicarboxylate). Yield 95%  
 
- NMR spectroscopy: 1H NMR (CDCl3D): δ(ppm) 7.5 (m, aromatic H), 5.3-5.0 (m, 
1H), 3.5 (m, 1H), 2.3 (m, 1H).  
- Mass spectroscopy: Mass spectrometry:ESI-MS(m/z):[M-H]+calcd.forC20H22NO5, 
356.4;found, 356.1.  
- IR spectroscopy: FT-IR (ATR) ν: 592, 692-792, 993, 1093, 1193, 1394, 1595-1695 
cm-1. 
 
3. Reaction C: Reagents Product (2) (dibenzyl (2S,4R)-4-hydroxypyrrolidine-1,2-
dicarboxylate) (1 eq, 2.81 mmol), 60% NaH (1.5 eq, 4.215 mmol), 
tetrabutylammonium iodide (0.1 eq, 0.281 mmol), tert butyl bromoacetate (4 eq, 






- Under an inert atmosphere, 10.6 ml of DRY THF and 0.1686 g NaH was added to 1 g 
of Product (2) (dibenzyl (2S,4R)-4-hydroxypyrrolidine-1,2-dicarboxylate) making 
a solution. 1.8 ml of tert butyl bromoacetate, 0.103 g of tetrabutylammonium 
iodide and 3 ml THF was added to the solution dropwise. The reaction is left 
overnight at room temperature. NH4Cl is added to the reaction mixture and after 
which the reaction was extracted with EtOAc, brine was used to wash, and the 
solution was dried with MgSO4. The solution was filtered and dried in the rotavap 
giving a yellowish oil. Crude was chromatographed using hexane/EtOAc 6:4 using a 
gradient system. 1.0 g of product (3) (dibenzyl (2S,4R)-4-(2-(tert-butoxy)-2-
oxoethoxy)pyrrolidine-1,2-dicarboxylate). Yield 67%. 
  
- NMR spectroscopy: 1H NMR (CDCl3D): δ(ppm) 7.5 (m, aromatic H), 5.3-5.0 (m, 
1H), 3.5 (m, 1H), 2.3 (m, 1H), 1.4 (s, 9H).  
- NMR spectroscopy: 13C NMR (CDCl3D): δ(ppm) 28, 36, 37, 52, 58, 70, 77, 81, 128, 
136, 155, 169, 173.  
- Mass spectroscopy: Mass spectrometry:ESI-MS(m/z):[M-H]+calcd.forC26H32NO7, 
470.5;found, 470.1.   
- IR spectroscopy: FT-IR (ATR) ν: 592, 692, 792, 893, 993-1093, 1193-1394, 1494, 
1795 cm-1. 





4. Reaction D: Reagents Pd/C 10% (eq 10%). Product (3) (dibenzyl (2S,4R)-4-(2-
(tert-butoxy)-2-oxoethoxy)pyrrolidine-1,2-dicarboxylate) (1 eq, 2.278 mmol). 
Solvents MeOH, EtOAc.  
 
- 1 g of product (3) (dibenzyl (2S,4R)-4-(2-(tert-butoxy)-2-oxoethoxy)pyrrolidine-
1,2-dicarboxylate) was dissolved in MeOH, 0.120 g Pd/C was dissolved in EtOAc 
and was added to the reaction mixture. The reaction vessel was evacuated by an 
aspirator and thoroughly purged with N2 (g) to give inert atmosphere. H2 (g) was 
added to vessel and mixture was stirred for 24 hours at room temperature. The 
mixture was filtered through and washed with MeOH. The solution is dried in the 
rotavap giving a reddish-brown sticky substance. 0.440 g of product (4) [(2S,4R)-4-
(2-(tert-butoxy)-2-oxoethoxy)pyrrolidine-2-carboxylic acid] was gained. Yield 
84%.  
 
- NMR spectroscopy: 1H NMR (CDCl3D): δ(ppm) 5.1 (s, 1H), 4.2 (m, 2H), 3.8 (m, 1H), 
1.4 (s, 9H).  
- Mass spectroscopy: ESI-MS(m/z):[M-H]+calcd.forC11H19NO5, 246.3;found, 246.2. 
- IR spectroscopy: FT-IR (ATR) ν: 592, 692, 792, 893, 993-1093, 1193-1394, 1494, 
1795, 2999 cm-1.  
 
5. Reaction E: Reagents Product (4) [(2S,4R)-4-(2-(tert-butoxy)-2-
oxoethoxy)pyrrolidine-2-carboxylic acid] (1 eq, 1.921 mmol), 
Fluorenylmethyloxycarbonyl chloride (1 eq, 1.921 mmol), NaHCO3 (2.1 eq, 





- 0.4406 g Product (4) [(2S,4R)-4-(2-(tert-butoxy)-2-oxoethoxy)pyrrolidine-2-
carboxylic acid] was dissolved in 3.5 ml of distilled H2O with 0.33 g NaHCO3 at 0oC. 
0.496 g Fluorenylmethyloxycarbonyl chloride was dissolved to 7 ml of THF, this 
solution was added dropwise slowly to the reaction mixture. At 0 oC the reaction 
mixture was stirred for 1 hr and then left overnight at room temperature. The reaction 
was cooled again and quenched with 0.1 M of HCl. The reaction was worked up; 
extracted with DCM, washed with brine, dried and filtered with MgSO4. The solution 
was dried in the rotavap. Yellowish oil was purified via recrystallisation. The solution 
was left In the freezer over 2 days, the compound still didn’t crash out fully, so the 
solution was removed using a rotavapor evaporator and then was purified via 
gradient chromatography with 9:1 DCM:MeOH, followed by a flushing the column 
with MeOH. The solvent was removed using a rotavap and then placed under high 
vacuum via a schlenk line overnight giving a yellowish oil. 110 mg of product (5) 
[(2S,4R)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-4-(2-(tert-butoxy)-2-
oxoethoxy)pyrrolidine-2-carboxylic acid] was gained. Yield 40% 
 
- NMR spectroscopy: 1H NMR (CDCl3D): δ(ppm) 8-7.5 (s,s,d aromatic H) 5.1 (s, 1H), 
4.2 (m, 2H), 3.8 (m, 1H), 1.4 (s, 9H). 
- NMR spectroscopy: 13C NMR (CDCl3D): δ(ppm) 176, 170, 164, 144, 141, 132, 131, 
128, 127, 126, 120, 82, 78, 68, 66, 58, 52, 48, 38, 37, 36, 31, 28, 26, 24.  
- Mass spectroscopy: ESI-MS(m/z):[M-H]+calcd.forC26H30NO7, 468.5;found, 468.1 
- IR spectroscopy: FT-IR (ATR) ν: 592, 692, 792, 893, 993-1093, 1193-1394, 1494, 
1695 cm-1.  





5.1.2 PP II design SPPS 
The following experimental was conducted in order to the hexamer PP6 design. SPPS 
methodology was conducted in a peptide synthesis vessel, and once again all reagents and 
solvents were purchased from the various trusted chemical manufactures mentioned 
previously: 
 
- Reagents: product (5) (2 eq), rink amide resin (1 eq, 0.0824 mmol), Fmoc-Proline-
OH (3 eq, 0.25 mmol) 0.13 g pyBop (3 eq, 0.25 mmol) HoBt 0.03 g (3 eq, 0.25 
mmol) and 0.06 g DIPEA (6 eq, 0.5 mmol) DTT, TIPS . Solvents: DMF, DCM, TFA, 
piperidine, Ac2O, DIPEA and DMF.  
 
1. 0.103 g Rink amide resin beads (1 eq, 0.0824 mmol) was placed inside a 
peptide reaction vessel and dissolved in DCM till the beads swell up and left 40 
minutes. DCM was pushed through with the compressed air and DMF was added 
and pushed out with compressed air 3x washing the swollen beads.  
2. The rink amide resin beads are deprotected using 8:2 DMF and pyridine solution 
and left to react for 10 minutes. The solution is pushed with compressed air and 
washed with DMF 3 x. 8:2 DMF and pyridine solution is added and left to spin for 
a further 10 minutes. The solution was pushed out with compressed air and 
washed with DMF 3x.  
3. The 1st coupling mixture was made up consisting of 0.09 g Fmoc-Proline-OH 
0.13 g pyBop, HoBt 0.03 g and 0.06 g DIPEA along with a minimum amount of 
DMF and was sonicated. This coupling mixture was added to the beads and was 
left for 2 hours. The solution was pushed out with compressed air and was 
washed with DMF 3x. An aliquot of the resin beads was taken and the Kaiser test 
was then added to beads, to see if successful.  
4. For the first coupling, a Capping mixture of 3 ml was added then which consisted 
of 10:2.5:100 Ac2O, DIPEA and DMF and left for to spin 1 hour. The solution was 
pushed out with compressed air and washed with DMF 3 x. An aliquot of the 
resin beads was taken and the kaiser test was deployed.  
5. For the 2nd coupling, the same deprotection mixture and procedure was followed 
as the 1st coupling. The 2nd coupling mixture consisting of 0.1 g product 5 (2 eq) 
0.13 g pyBop, 0.03 g HoBt and 0.06 g DIPEA and a minimum amount of DMF 
was added and solution was sonicated. Coupling mixture was added and left to 




DMF and DCM 3 x. An aliquot of the resin beads was taken, and the chlorophyll 
test performed.  
6. This pattern of coupling mixture was repeated four more times, with intermediate 
changing the proline with the coupling mixture  
7. On final 6th coupling, the same capping mixture was added as mentioned in the 
first coupling. The kaiser test was then added to the aliquot of beads.  
8. After the final coupling was successful the cleavage cocktail which consisted of 
1.32 ml TFA (88 %), 0.075 ml DTT (5 %), 0.075 ml TIPS (5 %) and 0.03 ml water 
(2 %) was added to the resin and left to mix for 30 minutes. The peptide reaction 
vessel tap was opened and allowing the solution to drip slowly into 15 ml of cold 
diethyl ether causing the solution to ‘crash out’ forming a white precipitate.  
9. The solution containing the white precipitate was placed into a ‘falcon tube’ in 
which the solution was centrifuged. The solution of diethyl ether was decanted, 
and 15 ml of diethyl ether was added to the falcon tube, centrifuged, sonicated 
and decanted off. This was repeated four times. Overall 44 mg of off-white solid 
consisting of the final product was gained. 
 
- NMR spectroscopy: 1H NMR (D2O): δ(ppm) 2-2.5 (m,m,m 20 H), 3.4-4.4 (m,m 12H), 
4.5-4.9 (m, s 18H).  
- NMR spectroscopy: 13 CNMR (D2O): δ(ppm) 47-48. 
- Mass spectroscopy: ESI-MS(m/z):[M-H]+calcd.for C38H53N7O16, 864.33; found 
864.34.  
- IR spectroscopy: FT-IR (ATR) ν: 792, 993, 1093, 1193, 1294, 1595, 1795 cm-1.  
5.2 Microfluidics microdroplet  
Below at figure 36 is a photo example from two different angles of the general setup when 
preparing for the microfluidic methodology. The setup consisted of two glass syringes, 
containing the different phases. One containing the water or aqueous phase and the other 
being the oil with 2% surfactant (silicone oil with Span 80 OR FC-40 with ‘sphere fluidic Pico-
surf’ surfactant). Each syringe was placed on two different syringe pumps; ‘Harvard apparatus 
22’ and ‘Pfizer world precision instrument’. One pump was set to a constant rate pumping the 
water or aqueous phase usually at rates of 15 microlitres per minute (this rate was sometimes 
modified very slightly to be higher or lower but remained relatively within this range). The other 
pump set at variable rates of 30-120 microlitres per minute pumping oil with 2% surfactant. 
The phases were pumped into ‘Saint-Gobain Tygon’ 1.6 mm internal diameter tubing which 
was attached via the omifit at the inputs into the junction PDMS cast microfluidic chips. At the 




watch glass. The watch glass was balanced on the lenses of the ‘MAOZUA’ USB microscope 
which observed microdroplets on the windows 10 camera software app to capture and record.  
 
Figure 36: Two photo example of set-up; two syringe pumps with tubing and omifit attached 




clamp hanging above watch glass. The watch glass is observed using USB microscope on 
window’s camera app.  
5.2.1 AutoCAD software, Microfluidic chip dimensions 
The following experimental is the AutoCAD dimensions of the microdroplet generating 
successful ‘T’ and ‘X’ junctions’ chips. As mentioned in section 2.2.6 and 2.2.4 of this thesis, 
the outlet sizes and overall length of the chips would be reduced in future work, however, the 
principle of the main dimensions of the 3-D printed chips was able to produce microdroplets. 
‘X’ junction below at figure 37 shows the length of the channels as well as the AutoCAD 
dimensions at the ‘X’ junction pinch with the measurements. ‘T’ junction below at figure 38 
shows the length of the channels as well as the AutoCAD dimensions at the ‘T’ junction pinch 
with the measurements. 
  
 
Figure 37: (A) Photo showing of the ‘X’ junction chip PDMS mould plasma cleaned lengths of 
channel indicated by the red arrows; (1) 15.8 mm, (2) 3 mm, (3) 3.6 mm, (4) 19.8 mm. (B) 
screenshot of the AutoCAD schematics of the ‘pinch’ of the ‘X’ junction diameter of the 














Figure 38: (A) Photo showing of the ‘T’ junction chip PDMS mould plasma cleaned channel 
indicated by the red arrows; (1) 19.6 mm (2) 12.3 mm. (B) screenshot of the AutoCAD 
schematics of the ‘pinch’ of the ‘T’ junction diameter of the channels indicated by the red 
arrows; (3) 0.2 mm (4) 0.1 mm. 
5.2.2 Chip manufacturing process 
Within this section the general outline from conception to creation of the microfluidic chips is 
described; 
1. AutoCAD microfluidic design was exported to the form labs 2 3-D printer software 
known as ‘PreForm’.  
2. PreForm preps the exported AutoCad designs, the resolution was set to 0.025 
mm and the file is sent to the ‘lab forms 2’ printer and is printed.  
3. The 3-D printed Clear Resin chip was cleaned in isopropanol and cured in the UV 
radiation chamber for 60 minutes.  
4. A mixture of 9:1 of 9 ml PDMS (Sylgard 184 silicone elastomer base) and 1 ml 
hardening agent (184 silicone elastomer curing agent) is mixed thoroughly 
together and then placed inside a vacuum chamber until the bubbles of the 
mixture had gone.  
5. The clear resin chips were placed inside a 3-D printed container shown at figure 
39 which was tailored towards the size of the chips enabling a ‘tight’ fit.  
6. The chips are slotted inside the resin container and the 10 ml mixture of PDMS 









figure 40 and was left In oven at 70-85 oC for 4-6 hours or overnight, (95-110 oC 
was possible to ensure much faster curing however the higher temperature 
caused slight bending to the resin chips).  
7. The PDMS mould of the chip was then gently cut out around the edges and 
pushed out from the bottom of the resin container.  
 
Figure 39: Photo of 3-D printed chip container, with hole at the bottom in order for more ease 
to push the PDMS cast mould out.  
 





After the PDMS cast has been created, the next step was plasma cleaning onto a glass 
surface. The ‘Electronic diener Zepto plasma surface technology’ plasma cleaner was 
available in this research and the method was as followed; 
8. The glass slide and PDMS mould were kept as clean as possible and free from 
dust. 
9. Both surfaces were placed topside in the plasma cleaner and placed under 
vacuum for 1 minute making the pressure half a bar inside.  
10. The oxygen supply was introduced into the plasma cleaner via the gas mainline 
for 1 minute increasing the pressure to 1 bar.  
11. The generator of the plasma cleaner was switch on for 1 minute applying 
electrons and free radicals to the surfaces.  
12. Finally, the plasma cleaner was ventilated and the glass slide and PDMS mould 
were taken out, and the PDMS cast mould surface microfluidic channel imprinted 
surface was pressed gently onto the glass slide forming a tight seal. Example of 
the final manufactured product has been referenced repeatedly throughout this 
thesis.   
Fluorinated microfluidic chips were also manufactured in order to generate microdroplets 
using FC-40 with 2 % sphere fluidic picosurf fluorinated surfactant. The same method was 
repeated with the one extra addition at the end of the process which was after the PDMS 
cast mould were plasma cleaned onto the glass surface FC-40 with 0.5 % 1H,1H,2H,2H-
perfluorooctyltriethoxysilane was immediately injected into the microfluidic channels using 
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Appendix 1: 1H NMR spectra product (1). Chemical structure of proline with benzyl attached 
and TsOH.   





Appendix 2: IR spectra of product (1), text file data convert to excel graph. Chemical structure 






































































































































































































































































































































































































Appendix 3: Chemical structure of proline with benzyl and Cbz group attached to the proline. 
NMR spectra of product (2) after Flash purification with the ‘Analytical grade’ petroleum ether 
solvent system along with ethyl acetate, showing significant ‘grease’ peaks in the lower 
chemical shift region.  





Appendix 4: 1H NMR of ‘analytical grade’ petroleum ether, showing the ‘grease’ peaks   





Appendix 5: NMR spectra of product (2) Chemical structure of proline with benzyl and Cbz 
group attached to the proline. after column purification with the ‘laboratory grade’ petroleum 
ether solvent system along with ethyl acetate, showing a big reduction of the ‘grease’ peaks 
in the lower chemical shift region.  





Appendix 6: IR spetra of product (2) text file data convert to excel graph. Chemical structure 





































































































































































































































































































































































































Appendix 7: 1H NMR of product (3). Chemical structure of proline with benzyl, Cbz and tert-
butyl acetate group attached to the proline  





Appendix 8: Chemical structure of proline with benzyl, Cbz and tert-butyl acetate group 
attached to the proline. 13C NMR spectra of product (3). 





Appendix 9: IR spectra of product (3) text file data convert to excel graph. Chemical structure 

















































































































































































































































































































































































































Appendix 10: 1H NMR spectra of product (4). Chemical structure of proline with tert-butyl 
acetate group.   





Appendix 11: IR spectra of product (4) text file data convert to excel graph. Chemical structure 




























































































































































































































































































































































































Appendix 12: 1H NMR spectra of product (5). Chemical structure of proline with tert-butyl 
acetate group and Fmoc.  





Appendix 13: IR spectra of product (5) text file data convert to excel graph. Chemical 



































































































































































































































































































































































































Appendix 14: 13C spectra of product (5) Chemical structure of proline with tert-butyl acetate 
group and Fmoc.  





Appendix 15: 1H NMR spectra of Hexamer PP6 design. 





Appendix 16: 13C NMR spectra of hexamer PP6 design.  






Appendix 17: MS spectra of hexamer PP6 design and retention time spectra of hexamer PP6 
design.  




Appendix 18: IR spectra of hexamer PP6 solid. text file data convert to excel graph 
 
 
Appendix 19: IR spectra of hexamer PP6 in TFE solution. text file data convert to excel graph 
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